Considerations for CPX-351 in Acute Myeloid Leukemia
2 Ansichten
• 07/04/23
0
0
Einbetten
administrator
Abonnenten
Expert panelists Eunice Wang, MD; Harry Erba, MD, PhD; Alexander E. Perl, MD; and Jorge E. Cortes, MD, identify important considerations when treating acute myeloid leukemia with CPX-351, such as its toxicity profile and patient stratification.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare